Health Profile

Patient Name : MR MD.YASEEN Bill Date : Mar 11, 2022, 07:30 p.m.
DOB/Age/Gender : 70 (Male) Sample Collected : Mar 11, 2022, 12:00 p.m.

Patient ID : 202368 Sample Received : Mar 11, 2022, 07:31 p.m.
Referred By : SELF Report Date : Mar 11, 2022, 10:47 p.m.
Sample Type : Serum Barcode No : 12249507022
Client : Home Collection - Delhi -
Test Description Value(s) Unit(s) Reference Range
SMART PLUS FULL BODY CHECKUP + VITAMIN SCREENING

Vitamin D 25 - Hydroxy
25-Hydroxy Vitamin D Total 45.69 ng/mL Deficiency : < 10 ng/mL
Method : ECLIA Insufficient : 10-30 ng/mL
Sufficient : 30-100 ng/mL
Hypervitaminosis : > 100 ng/mL
Interpretation:
25-Hydroxy vitamin D represents the main body reservoir and transport form. Mild to moderate deficiency is associated with
Osteoporosis / Secondary Hyperparathyroidism while severe deficiency causes Rickets in children and Osteomalacia in adults.
Prevalence of Vitamin D deficiency is approximately >50% specially in the elderly. This assay is useful for diagnosis of vitamin D
deficiency and Hypervitaminosis D. It is also used for differential diagnosis of causes of Rickets & Osteomalacia and for monitoring
Vitamin D replacement therapy.
"Patients on Biotin supplement may have interference in some immunoassays. Ref: Arch Pathol Lab Med—Vol 141, November
2017. With individuals taking high dose Biotin (more than 5 mg per day) supplements, at least 8-hour wait time before blood draw is
recommended."
**END OF REPORT**
Scan to Validate
Page 1 of 18
Sample Type : Edta Wb Barcode No : 12249307022

CBC with ESR
Hemoglobin 14.4 g/dL 13 - 17
Method : Spectrophotometry
RBC Count 4.92 10*6/uL 4.5 - 5.5
Method : Electrical Impedance
PCV 45.5 % 40.0 - 50.0
Method : Calculated
MCV 92.6 fL 80.0 - 100.0
Method : Calculated
MCH 29.3 pg 27.0 - 32.0
Method : Calculated
MCHC 31.7 g/dL 32.0 - 35.0
Method : Calculated
RDW (CV) 14.7 % 11.5 - 14.5
Method : Calculated
RDW-SD 48.6 fL 35.1 - 43.9
Method : Calculated
TLC 9.04 10*3/uL 4.0 - 10.0
Method : Electrical impedance & microscopy
DIFFERENTIAL LEUCOCYTE COUNT

Neutrophils 61.3 % 40.0 - 80.0
Lymphocytes 24.2 % 20 - 40
Monocytes 7.4 % 2.0 - 10.0
Eosinophils 6.7 % 1.0 - 6.0
Basophils 0.40 % < 2.0
Scan to Validate
Page 2 of 18
ABSOLUTE LEUCOCYTE COUNT

Neutrophils* 5.54 103/uL 2.0 - 7.0
3
Lymphocytes* 2.19 10 /uL 1.0 - 3.0
Monocytes* 0.67 103/uL 0.20 - 1.0
3
Eosinophils* 0.61 10 /uL 0.02 - 0.50
3
Basophils* 0.04 10 /uL 0.01 - 0.10
Platelet Count 210 10*3/uL 150.0 - 450.0
Method : Electrical impedance and microscopy
Mean Platelet Volume (MPV) 11.3 fL 9.3 - 12.1
Method : Electric Impedence
PCT 0.24 % 0.17 - 0.32
Method : Electric Impedence
PDW 13.4 fL 8.3 - 25.0
Mentzer Index 18.82 %
ESR - Erythrocyte Sedimentation Rate 16 mm/hr 0-22
Method : EDTA Whole Blood, Manual Westergren
Interpretation
CBC provides information about red cells, white cells and platelets. Results are useful in the diagnosis of anemia, infections,
leukemias, clotting disorders and many other medical conditions.
Comment :
**END OF REPORT**
Scan to Validate
Page 3 of 18

HbA1C (Glycosylated Hemoglobin)
GLYCOSYLATED HEMOGLOBIN (HbA1c) 5.5 % < 6.5
Method : HPLC
ESTIMATED AVERAGE GLUCOSE 111.15 mg/dL -
Interpretation For HbA1c% As per American Diabetes Association (ADA)
Reference Group HbA1c in %
Non diabetic adults >=18 years <5.7
At risk (Prediabetes) 5.7 - 6.4
Diagnosing Diabetes >= 6.5
Age > 19 years
Goal of therapy: < 7.0

Therapeutic goals for glycemic control
Age < 19 years
Goal of therapy: <7.5
Note:
1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a diabetic patient who is recently under good control may still have a high concentration of HbA1c. Converse is true
for a diabetic previously under good control but now poorly controlled. 2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long life expectancy and no significant
cardiovascular disease. In patients with significant complications of diabetes, limited life expectancy or extensive co-morbid conditions, targeting a goal of < 7.0 % may not be appropriate.
Comments :
HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better indicator of long term glycemic control as compared to blood and urinary glucose
determinations ADA criteria for correlation between HbA1c & Mean plasma glucose levels
HbA1c(%) Mean Plasma Glucose (mg/dL) HbA1c(%) Mean Plasma Glucose (mg/dL)
6 126 12 298
8 183 14 355
Scan to Validate
Page 4 of 18
10 240 16 413
**END OF REPORT**
Scan to Validate
Page 5 of 18
Sample Type : Fluoride F Barcode No : 12249407022

Glucose-Fasting
GLUCOSE FASTING 101.7 mg/dL Normal: 70-99
Method : Hexokinase Impaired Tolerance: 100-125
Diabetes mellitus: >= 126
(on more than one occassion)
(American diabetes association
guidelines 2018)
Comment :
**END OF REPORT**
Scan to Validate
Page 6 of 18

Liver Function Test
BILIRUBIN TOTAL 0.38 mg/dL 0.2 - 1.2
Method : Diazo with Sulphanilic acid
BILIRUBIN DIRECT 0.14 mg/dL 0.0 - 0.5
Method : Diazonium
BILIRUBIN INDIRECT 0.24 mg/dL 0.1 - 1.0
Method : Calculation (T Bil - D Bil)
SGOT/AST 27.7 U/L 5 - 35
Method : IFCC without P5P
SGPT/ALT 21.7 U/L 5 - 45
Method : IFCC without P5P
SGOT/SGPT Ratio 1.28 -
ALKALINE PHOSPHATASE 79 U/L 30 - 120
Method : PNPP-AMP Buffer/Kinetic
TOTAL PROTEIN 7.15 g/dL 6.0 – 8.2
Method : Biuret
ALBUMIN 4.02 g/dL 3.8 – 5.0
Method : BCG
GLOBULIN 3.13 g/dL 2.3 - 3.5
Method : Calculation (T.P - Albumin)
ALBUMIN : GLOBULIN RATIO 1.28 1.0 - 2.1
Method : Calculation (Albumin/Globulin)
GAMMA GLUTAMYL TRANSFERASE (GGT) 31 U/L 5 - 40
Method : ENZYMATIC
Interpretation
Scan to Validate
Page 7 of 18
The liver filters and processes blood as it circulates through the body. It metabolizes nutrients, detoxifies harmful substances, makes blood clotting proteins, and performs many
other vital functions. The cells in the liver contain proteins called enzymes that drive these chemical reactions. When liver cells are damaged or destroyed, the enzymes in the
cells leak out into the blood, where they can be measured by blood tests Liver tests check the blood for two main liver enzymes. Aspartate aminotransferase (AST),SGOT: The
AST enzyme is also found in muscles and many other tissues besides the liver. Alanine aminotransferase (ALT), SGPT: ALT is almost exclusively found in the liver. If ALT and
AST are found together in elevated amounts in the blood, liver damage is most likely present. Alkaline Phosphatase and GGT: Another of the liver's key functions is the
production of bile, which helps digest fat. Bile flows through the liver in a system of small tubes (ducts), and is eventually stored in the gallbladder, under the liver. When bile flow
is slow or blocked, blood levels of certain liver enzymes rise: Alkaline phosphatase Gamma-utamyl transpeptidase (GGT) Liver tests may check for any or all of these enzymes in
the blood. Alkaline phosphatase is by far the most commonly tested of the three. If alkaline phosphatase and GGT are elevated, a problem with bile flow is most likely present.
Bile flow problems can be due to a problem in the liver, the gallbladder, or the tubes connecting them. Proteins are important building blocks of all cells and tissues. Proteins are
necessary for your body's growth, development, and health. Blood contains two classes of protein, albumin and globulin. Albumin proteins keep fluid from leaking out of blood
vessels. Globulin proteins play an important role in your immune system. Low total protein may indicate: 1.bleeding 2.liver disorder 3.malnutrition 4.agammaglobulinemia High
Protein levels 'Hyperproteinemia: May be seen in dehydration due to inadequate water intake or to excessive water loss (eg, severe vomiting, diarrhea, Addison's disease and
diabetic acidosis) or as a result of increased production of proteins Low albumin levels may be caused by: 1.A poor diet (malnutrition). 2.Kidney disease. 3.Liver disease. High
albumin levels may be caused by: Severe dehydration.
**END OF REPORT**
Scan to Validate
Page 8 of 18

Kidney Function Test
Kidney Function Test

BLOOD UREA 37.4 mg/dL 15.4 - 48.0
Method : Urea GLDH
CREATININE 1.19 mg/dL 0.6 - 1.2
Method : Enzymatic-Creatinine Amidohydrolase
URIC ACID 5.3 mg/dL 4.0 – 8.5
Method : Uricase/peroxidase (colorimetric)
BUN 17.48
Method : Calculated
BUN/CREATININE RATIO 14.69
Method : Calculated
CALCIUM 9.29 mg/dL 8.9 - 10.7
Method : O-Cresolphthalein Complex
PHOSPHORUS 3.43 mg/dL 2.3 - 4.7
Method : Colorimetric - Phosphomolybdate
Formation
SODIUM 140.78 mmol/L 135.0 - 145.0
Method : ISE
POTASSIUM 3.78 mmol/L 3.7 - 5.6
Method : ISE
CHLORIDE 101.78 mmol/L 95 - 107
Method : ISE
Interpretation
Scan to Validate
Page 9 of 18
SUMMARY:-Kidney function tests is a collective term for a variety of individual tests and proceduresthat can be done toevaluate how well the kidneys are functioning.Many conditions can affect the
ability of the kidneys to carryout their vital functions. Somelead to a rapid (acute) decline in kidney functionothers lead to a gradual (chronic) declineinfunction. Both result in a buildup of toxic waste
subst done on urine samples, as well as on blood samples.A number of symptoms may indicate a problem with your kidneys. These include : high blood pressure,blood in urine frequent urges to
urinate,difficulty beginning urination,painful urination,swelling in the hands and feet due to a buildup of fluids in the body. A single symptom may not mean something serious. However, when occurring
simultaneously, these symptoms suggest that your kidneys are not working properly. Kidney function tests can help determine the reason. Electrolytes (sodium,potassium,and chloride) are present in
the human body and the balancing act of the electrolytes in our bodies is essential for normal function of our cells and organs. There has to be a balance.Ionized calcium this test if you have signs of
kidney or parathyroid disease. The test may also be done to monitor progress and treatment of these diseases.
**END OF REPORT**
Scan to Validate
Page 10 of 18

Lipid Screen
TOTAL CHOLESTEROL 289.2 mg/dL Desirable : <200
Method : Enzymatic - Cholesterol Oxidase Borderline : 200-239
High : >240
TRIGLYCERIDES 199.7 mg/dL Normal : <150
Method : Colorimetric - Lip/Glycerol Kinase Borderline : 150-199
High : 200-499
Very high : >500
HDL CHOLESTEROL 44.4 mg/dL 35 - 60
Method : Phosphotungstic acid- Enzymatic
NON HDL CHOLESTEROL 244.80 mg/dL <130
Method : Calculated
LDL CHOLESTEROL 204.86 mg/dL Desirable : <100
Near optimal : 100-129
Borderline : 130-159
High : >160
V.L.D.L CHOLESTEROL 39.94 mg/dL < 30
Method : Calculation
CHOL/HDL Ratio 6.51 3.5 - 5.0
Method : Calculated
HDL/ LDL RATIO 0.22 Desirable : 0.5 - 3.0
Method : Calculated Borderline : 3.1 - 6.0
High : > 6.0
LDL/HDL Ratio 4.61 -
Method : Calculated
Interpretation
Scan to Validate
Page 11 of 18
Lipid level assessments must be made folloeing 9 to 12 hours of fasting,otherwise assay results might lead to erroneos interpretatio
NCEP recmmends of 3 different samples drawn at intervals of 1 week for harmonizing biological variables that might be encountered
in single assays.
NATIONAL LIPID
ASSOCIATION TOTAL CHOLESTEROL in LDL CHOLESTEROL in NON HDL CHOLESTEROL
TRIGLYCERIDE in mg/dL
RECOMMENDATIONS mg/dL mg/dL in mg/dL
(NLA-2014)
Optimal <200 <150 <100 <130
Above Optimal 100-129 130 - 159
Borderline High 200-239 150-199 130-159 160 - 189
High >=240 200-499 160-189 190 - 219
Very High - >=500 >=190 >=220
**END OF REPORT**
Scan to Validate
Page 12 of 18

Vitamin B12
Vitamin - B12 1429 pg/mL 187 - 883
Method : ECLIA
Interpretation :
Low Values are a sign of a vitamin B12 deficiency. People with this deficiency are likely to have or develop symptoms.
Causes of vitamin B12 deficiency include:Not enough vitamin B12 in diet (rare except with a strict vegetarian diet), Diseases that
cause malabsorption (for example, celiac disease and Crohn's disease), Lack of intrinsic factor, Above normal heat production (for
example, with hyperthyroidism), Pregnancy. Increased vitamin B12 levels are uncommon. Usually excess vitamin B12 is removed in
the urine. Conditions that can increase B12 levels include: Liver disease (such as cirrhosis or hepatitis), Myeloproliferative disorders
(for example, polycythemia vera and chronic myelocytic leukemia).
Vitamin B12: Low Levels can cause malabsorption, Lack of intrinsic factor, Above normal heat production (for example, with
hyperthyroidism), Pregnancy.High Level Liver disease, Myeloproliferative disorders (for example, polycythemia vera and chronic
myelocytic leukemia).
1. Out of 140 healthy indian population, 91% of Vitamin B 12 concentrations was at lower level: 59.00 pg/ml and upper level: 700.00
pg/ml
"Patients on Biotin supplement may have interference in some immunoassays. Ref: Arch Pathol Lab Med—Vol 141, November
2017. With individuals taking high dose Biotin (more than 5 mg per day) supplements, at least 8-hour wait time before blood draw is
recommended."
**END OF REPORT**
Scan to Validate
Page 13 of 18

Thyroid Profile Total
TRIIODOTHYRONINE ( T3 ) 106 ng/dL 70 - 204
Method : ECLIA
TOTAL THYROXINE ( T4 ) 7.99 µg/dL 5.0 - 12.5
Method : ECLIA
TSH 2.2 mlU/L 0.54 - 5.3
Method : ECLIA
Interpretation :
Primary malfunction of the thyroid gland may result in excessive (hyper) or below normal (hypo) release of T3 or T4. In addition as TSH directly affects thyroid function, malfunction of the pituitary or
the hypo - thalamus influences the thyroid gland activity. Disease in any portion of the thyroid-pitutary-hypothala- mus system may influence the levels of T3 and T4 in the blood. In primary
hypothyroidism, TSH levels are significantly elevated, while in secondary and tertiary hypothyroidism, TSH levels may be low. In addition, in the Euthyroid Sick Syndrome, multiple alterations in serum
thyroid function test findings have been recognized in patients with a wide variety of non-thyroidal illnesses (NTI) without evidence of preexisting thyroid or hypothalami c-pitutary diseases. Thyroid
Binding Globulin (TBG) concentrations remain relatively constant in healthy individuals. However, pregnancy, excess estrogen's, androgen's, antibiotic steroids and glucocorticoids are known to alter
TBG levels and may cause false thyroid values for Total T3 and T4 tests.
TSH T4 T3 INTERPRETATION
High Normal Normal Mild (subclinical) hypothyroidism
High Low Low or normal Hypothyroidism
Low Normal Normal Mild (subclinical) hyperthyroidism
Low High or normal High or normal Hyperthyroidism
Nonthyroidal illness; pituitary (secondary)

Low Low or normal Low or normal
hypothyroidism
Thyroid hormone resistance syndrome (a
Normal High High mutation in the thyroid hormone receptor
decreases thyroid hormone function)
**END OF REPORT**
Scan to Validate
Page 14 of 18
Sample Type : Urine Barcode No : 12249607022

Urine Routine & Microscopic Examination
Physical Examination
Volume 20 ml
Colour* Pale Yellow Pale Yellow
Transparency (Appearance)* Clear Clear
Deposit* Absent Absent
Reaction (pH)* 7 4.5 - 8
Specific Gravity* 1.010 1.010 - 1.030
Chemical Examination (Automated Dipstick Method)

Urine Glucose (sugar)* Negative Negative
Urine Protein (Albumin)* Negative Negative
Urine Ketones (Acetone)* Negative Negative
Blood* Negative Negative
Leucocyte esterase Negative Negative
Nitrite* Negative Negative
Urobilinogen* Normal Normal
Microscopic Examination
Pus Cells (WBCs)* 2-3 /hpf 0-5
Epithelial Cells* 1-2 /hpf 0-4
Red blood Cells* Absent /hpf Absent
Crystals* Absent Absent
Cast* Absent Absent
Yeast Cells* Absent Absent
Amorphous deposits* Absent Absent
Scan to Validate
Page 15 of 18
Sample Type : Urine Barcode No : 12249607022
Bacteria* Absent Absent
**END OF REPORT**
Scan to Validate
Page 16 of 18
Prostate Specific Antigen (PSA) Total

PROSTATE SPECIFIC ANTIGEN-TOTAL 7.57 ng/mL
(PSA-TOTAL)
Method : ECLIA
Interpretation
Age (years) Ranges
< 40 1.4
40 - 49 2.0
50 - 59 3.1
60 - 69 4.1
>=70 4.4
Prostate Specific Antigen (PSA) is a single-chain glycoprotein normally found in the cytoplasm of the epithelial cells lining the acini and ducts of the prostate gland. PSA is detected in the serum of
males with normal, benign hyperplastic and malignant prostate tissue and in patients with prostatitis. PSA is not detected (or detected at very low levels) in the serum of males without prostate tissue
(because of radical prostatectomy or cytoprostatectomy) or in the serum of most females. The fact that PSA is unique to prostate tissue makes it a suitable marker for monitoring men with cancer of
the prostate. PSA is also useful for determining possible recurrence after therapy when used in conjunction with other diagnostic indices. PSA levels increase in men with cancer of the prostate. After
radical prostatectomy PSA levels routinely fall to a very low level, which may not be seen in patients undergoing radiation therapy. Monitoring PSA levels appears to be useful in detecting residual
disease and early recurrence of tumor. Therefore, serial PSA levels can help determine the success of prostatectomy and the need for further treatment, such as radiation, endocrine of chemotherapy
and in the monitoring of the effectiveness of therapy.
PSA levels should not be interpreted as absolute evidence of presence or the absence of malignant disease. Before treatment, patients with confirmed prostate carcinoma frequently have levels of
PSA within the range observed in healthy individuals. Elevated levels of PSA can be observed in the patients with nonmalignant disease. Measurement of PSA should always be used in conjunction
with other diagnostic procedures, including information from the patients and clinical evaluation.
The concentration of total PSA in a given specimen determined with assays from different manufacturers can vary due to differences in assay methods, calibration, and reagent specificity.
**END OF REPORT**
Scan to Validate
Page 17 of 18
CONDITIONS OF REPORTING
1. It is presumed that specimen belongs to patient named or identified, such verification being carried out at the point of generation of
said specimen
2. A test might not be performed due to following reasons:
- Specimen Quantity not sufficient (Inadequate collection/spillage during transit)

- Specimen Quality not acceptable (Hemolysis/clotted/lipemic.)
- Incorrect sample type
- Test cancelled either on request of patient or doctor
In any of the above case a fresh specimen will be required for testing and reporting
3. The results of the tests may vary from lab to lab; time to time for the same patient
4. The reported results are dependent on individual assay methods, equipment, method sensitivity, specificity and quality of the
specimen received
5. Partial representation of report is not allowed
6. The reported tests are for the notification of the referring doctor, only to assist him/her in the diagnosis and management of the
patient
7. If Sample collection date is not stated on test requisition form, the current date will be printed by default as the date of collection.
8. Report with status "Preliminary" means one or more test are yet to be reported
9. This report is not valid for Medico Legal Purpose
10. Applicable Jurisdiction will be of "Delhi" for any dispute/claim concerning the test(s) & results of the test(s)
Page 18 of 18

Health Profile

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Health Profile

Uploaded by

Copyright:

Available Formats

Patient Name : MR MD.YASEEN Bill Date : Mar 11, 2022, 07:30 p.m.

DOB/Age/Gender : 70 (Male) Sample Collected : Mar 11, 2022, 12:00 p.m.

Test Description Value(s) Unit(s) Reference Range

SMART PLUS FULL BODY CHECKUP + VITAMIN SCREENING

Test Description Value(s) Unit(s) Reference Range

SMART PLUS FULL BODY CHECKUP + VITAMIN SCREENING

DIFFERENTIAL LEUCOCYTE COUNT

Test Description Value(s) Unit(s) Reference Range

ABSOLUTE LEUCOCYTE COUNT

Test Description Value(s) Unit(s) Reference Range

SMART PLUS FULL BODY CHECKUP + VITAMIN SCREENING

Interpretation For HbA1c% As per American Diabetes Association (ADA)

Reference Group HbA1c in %

Non diabetic adults >=18 years <5.7

At risk (Prediabetes) 5.7 - 6.4

Diagnosing Diabetes >= 6.5

Age > 19 years

Goal of therapy: < 7.0

Goal of therapy: <7.5

Test Description Value(s) Unit(s) Reference Range

Test Description Value(s) Unit(s) Reference Range

SMART PLUS FULL BODY CHECKUP + VITAMIN SCREENING

Test Description Value(s) Unit(s) Reference Range

SMART PLUS FULL BODY CHECKUP + VITAMIN SCREENING

Test Description Value(s) Unit(s) Reference Range

albumin levels may be caused by: Severe dehydration.

Test Description Value(s) Unit(s) Reference Range

SMART PLUS FULL BODY CHECKUP + VITAMIN SCREENING

Kidney Function Test

Test Description Value(s) Unit(s) Reference Range

Test Description Value(s) Unit(s) Reference Range

SMART PLUS FULL BODY CHECKUP + VITAMIN SCREENING

Test Description Value(s) Unit(s) Reference Range

Optimal <200 <150 <100 <130

Above Optimal 100-129 130 - 159

Borderline High 200-239 150-199 130-159 160 - 189

High >=240 200-499 160-189 190 - 219

Very High - >=500 >=190 >=220

Test Description Value(s) Unit(s) Reference Range

SMART PLUS FULL BODY CHECKUP + VITAMIN SCREENING

Test Description Value(s) Unit(s) Reference Range

SMART PLUS FULL BODY CHECKUP + VITAMIN SCREENING

High Normal Normal Mild (subclinical) hypothyroidism

High Low Low or normal Hypothyroidism

Low Normal Normal Mild (subclinical) hyperthyroidism

Low High or normal High or normal Hyperthyroidism

Nonthyroidal illness; pituitary (secondary)

Thyroid hormone resistance syndrome (a

Normal High High mutation in the thyroid hormone receptor

decreases thyroid hormone function)

Test Description Value(s) Unit(s) Reference Range

SMART PLUS FULL BODY CHECKUP + VITAMIN SCREENING

Chemical Examination (Automated Dipstick Method)

Test Description Value(s) Unit(s) Reference Range

Bacteria* Absent Absent

Test Description Value(s) Unit(s) Reference Range

Prostate Specific Antigen (PSA) Total

and in the monitoring of the effectiveness of therapy.

2. A test might not be performed due to following reasons:

- Specimen Quantity not sufficient (Inadequate collection/spillage during transit)

5. Partial representation of report is not allowed

9. This report is not valid for Medico Legal Purpose

You might also like